Immunosuppressive effect of silibinin in experimental autoimmune encephalomyelitis (original) (raw)

References

• Aktas, O., Prozorovski, T., Smorodchenko, A., Savaskan, N., Lauster, R., Kloetzel, P., Infante-Duarte, C, Brocke, S., and Zipp, F., Green tea epigallocatechin-3-gallate mediates T cellular NF-kB inhibition and exerts neuroprotection in autoimmune encephalomyelitis.J. Immunol., 173, 5794- 5800 (2004).
  PubMed CAS Google Scholar
• Bitsch, A., Schuchardt, J., Bunkowski, S., Kuhlmann, T., and Bruck, W., Acute axonal injury in multiple sclerosis.Brain, 123,1174–1183(2000).
  Article PubMed Google Scholar
• Cudrici, C, Niculescu, T., Niculescu, F., Shin, M. L., and Rus, H., Oligodendrocyte cell death in pathogenesis of multiple sclerosis: Protection of oligodendrocytes from apoptosis by complement.J. Rehab. Res. Devel., 43, 123–132 (2006).
  Article Google Scholar
• Deep, G., Singh R. P., Agarwal, C, Kroll, D. J., and Agarwal, R., Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin.Oncogene, 25, 1053–1069(2006).
  Article PubMed CAS Google Scholar
• El Behi, M., Dubucquoi, S., Lefranc, D., Zephir, H., De Seze, J., Vermersch, P., and Prin, L., New insights into cell responses involved in experimental autoimmune encephalomyelitis and multiple sclerosis.Immunol. Lett., 96, 11–26 (2005).
  Article PubMed CAS Google Scholar
• Fazilleau, N., Delarasse, C., Sweenie, C., Anderton, S., Fillatreau, S., Lemonnier, F., Pham-Dinh, D., and Kanellopoulos, J., Persistence of autoreactive myelin oligodendrocyte glycoprotein (MOG)-specific T cell repertoires in MOG-expressing mice.Eur. J. Immunol., 36, 533–543 (2006).
  Article PubMed CAS Google Scholar
• Ford, M. and Evavold, B., Modulation of MOG 37-50-specific CD8+ T cell activation and expansion by CD43.Cell. Immunol., 240, 53–61 (2006).
  Article PubMed CAS Google Scholar
• Friese, M. and Fugger, L., Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy?Brain, 128, 1747–1763 (2005).
  Article PubMed Google Scholar
• Gay, F., Drye, T., Dick, G, and Esiri, M., The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis.Brain, 120, 1461–1483 (1997).
  Article PubMed Google Scholar
• Goverman, J., Perchellet, A., and Huseby, E., The role of CD8+ T cells in multiple sclerosis and its animal models. Curr. Drug Targets Inflamm.Allergy, 4, 239–245 (2005).
  CAS Google Scholar
• Hendrikes, J., Alblas, J., van der Pol, S., van Tol, E., Dijkstra, C, and de Vries, H., Flavonoids influence monocytic GTPase activity and Are protective in experimental allergic encephalitis.J. Exp. Med., 200, 1667–1672 (2004).
  Article Google Scholar
• Imitola, J., Chitnis, T, and Khoury, S., Cytokines in multiple sclerosis: from bench to bedside.Pharmacol. Therap., 106, 163–177(2005).
  Article CAS Google Scholar
• Jacobs, B., Dennehy, C, Ramirez, G, Sapp, J., and Lawrence, V, Milk thistle for the treatment of liver disease: a systematic review and meta-analysis.Am. J. Med., 113, 506–515 (2002).
  Article PubMed Google Scholar
• Johnson, V, He, Q., Osuchowski, M., and Sharma, R., Physiological responses of a natural antioxidant flavonoid mixture, silymarin, in BALB/c mice.Planta Med., 69,44–49 (2003).
  Article PubMed CAS Google Scholar
• Kang, J. S., Jeon, Y J., Park, S. K., Yang, K. H., and Kim, H. M., Protection against lipopolysaccharide-induced sepsis and inhibition of interleukin-1â and prostaglandin E2 synthesis by silymarin.Biochem. Pharmacol., 67, 175–181 (2003).
  Article Google Scholar
• Kerlero de Rosbo,andBen-Nun, A., T-cell responses to myelin antigens in multiple sclerosis; relevance of the predominant autoimmune reactivity to myelin oligodendrocyte glycoprotein.J. Autoimmun., 11, 287–299 (1998).
  Article PubMed Google Scholar
• Khalil, M., Reindl, M., Lutterotti, A., Kuenz, B., Ehling, R., Gneiss, C, Lackner, P., Deisenhammer, F., and Berger, T., Epitope specificity of serum antibodies directed against the extracellular domain of myelin oligodendrocyte glycoprotein: Influence of relapses and immunomodulatory treatments.J. Neuroimmunol., 174, 147–56(2005).
  Article Google Scholar
• Komiyama, Y, Nakae, S., Matsuki, T, Nambu, A., Ishigame, H., Kakuta, S., Sudo, K., and Iwakura, Y, IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis.J. Immunol., 177, 566–573 (2006).
  PubMed CAS Google Scholar
• Kren, V. and Walterova, D., Silybin and silymarin - new effects and applications.Biomed. Papers, 149(1), 29–41 (2005).
  CAS Google Scholar
• Kuhlmann, T., Lingfeld, G, Bitsch, A., Schuchardt, J., and Bruck, W., Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time.Brain, 125, 2202–2212 (2002).
  Article PubMed Google Scholar
• Lee, J., Kim, S., Kim, H., Lee, T., Jeong, Y, Lee, C, Yoon, M., Na, Y, Suh, D., Park, N., Choi, I., Kim, G, Choi, Y, Chung, H., and Park, Y, Silibinin polarized Th1/Th2 immune responses through the inhibition of immunostimulatory function of dendritic cells.J. Cell. Physiol., (2006).
• Mandel, M., Gurevich, M., Lavie, G, Cohen, I., and Achiron, A., Unique gene expression patterns in human T-cell lines generated from multiple sclerosis patients by stimulation with a synthetic MOG peptide.Clin. Devel. Immunol., 12(3), 203- 209 (2005).
  Article CAS Google Scholar
• Muthian, G and Bright, J., Quercetin, a flavonoid phytoestrogen, ameliorates experimental allergic encephalomyelitis by blocking IL-12 signaling through JAK-STAT pathway in T lymphocyte.J. Clin. Immunol., 24, 542–552 (2004).
  Article PubMed CAS Google Scholar
• Owens, T, The enigma of multiple sclerosis: inflammation and neurodegeneration cause heterogenous dysfunction and damage.Curr. Opin. Neurol., 16, 259–265 (2003).
  Article PubMed Google Scholar
• Schumann, J., Prockl, J., Kiemer, A., Vollmar, A., Bang, R., and Tiegs, G, Silibinin protects mice from T cell-dependent liver injury.J. Hepatol., 39, 333–340 (2003).
  Article PubMed CAS Google Scholar
• Stuve, O., Youssef, S., Weber, M., Nessler, S., von Budinger, H., Hemmer, B., Prod’homme, T., Sobel, R., Steinman, L., and Zamvil, S., Immunomodulatory synergy by combination of atorvastatin and glatiramer acetate in treatment of CNS autoimmunity.J. Clin. Invest, 116(4), 1037–1044 (2006).
  Article PubMed CAS Google Scholar
• Sun, D., Newman, T., Perry, V., and Weiler, R., Cytokine-induced enhancement of autoimmune inflammation in the brain and spinal cord: implications for multiple sclerosis.Neuropathol. Appl. Neurobiol., 30, 374–384 (2004).
  Article PubMed CAS Google Scholar
• Thelen, P., Jarry, H., Ringert, R., and Wuttke, W., Silibinin down- reglates prostate epithelium-derived Ets transcription factor in LNCaP prostate cancer cells.Planta Med., 70, 397–400 (2004).
  Article PubMed CAS Google Scholar
• Van den Broek, H., Damoiseaux, J., de Baets, M., and Hupperts, R., The influence of sex hormones on cytokines in multiple sclerosis and experimental autoimmune encephalomyelitis: a review.Mult. Scler., 11, 349–359 (2005).
  Article PubMed Google Scholar
• Zhang, G X., Yu, S., Gran, B., and Rostami, A., Glucosamine abrogates the acute phase of experimental autoimmune encephalomyelitis by induction of Th2 response.J. Immunol., 175,7202–7208(2005).
  PubMed CAS Google Scholar
• Zhao, J. and Agarwal, R., Tissue distribution of silibinin, the major active constituent of silymarin, in mice and its association with enhancement of phase II enzymes: implications in cancer chemoprevention.Carcinogenesis, 20(11), 2101–2108(1999).
  Article PubMed CAS Google Scholar

Download references